EP3106192A1 — Dose setting and dose limiting mechanism for an injection device and method for programming the dose limitation
Assigned to Tecpharma Licensing AG · Expires 2016-12-21 · 9y expired
What this patent protects
A dose setting mechanism for an injection device that limits the setting of a dose beyond a predetermined amount of medication. The mechanism is based on a first stop element (400) that reciprocates between a first position and a second position during the dose setting and dose d…
USPTO Abstract
A dose setting mechanism for an injection device that limits the setting of a dose beyond a predetermined amount of medication. The mechanism is based on a first stop element (400) that reciprocates between a first position and a second position during the dose setting and dose delivery step, and a second stop element (300) that moves unidirectionally during dose delivery. The first and second stop elements both have limiters (301)(401)and the axial or angular distance between the two limiters is reduced during dose setting and remains contact during dose delivery whereby the setting of a dose exceeding a predetermined amount of medication is prevented when the two limiters are engaged. Furthermore, a method for assembly and programming the predetermined amount of medication that can be dispensed from the injection device is presented.
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.